Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
暂无分享,去创建一个
Anne Vincent-Salomon | Valérie Choesmel | J. Thiery | A. Vincent-Salomon | J. Pierga | C. Nos | V. Choesmel | Brigitte Sigal-Zafrani | Jean-Yves Pierga | Jean-Paul Thiery | Claude Nos | Nathalie Blin | N. Blin | B. Sigal‐Zafrani
[1] William E Gillanders,et al. Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] O. Myklebost,et al. Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates. , 1999, Molecular pathology : MP.
[3] R. Faye,et al. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] James N Ingle,et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] T. Dimpfl,et al. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma , 2000, Cancer.
[6] G. Bastert,et al. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19 , 2000, Journal of Cancer Research and Clinical Oncology.
[7] R. Coombes,et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study , 1999, The Lancet.
[8] B. Wollenberg,et al. Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule. , 2001, Cancer.
[9] A. Giuliano,et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] C. Robson,et al. Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression. , 1998, Cytometry.
[11] A. Oosterom,et al. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] G Kvalheim,et al. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] S. Braun,et al. Tumor–antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease , 1999, International journal of cancer.
[14] U. Schumacher,et al. Epithelial Glycoprotein-2 Expression is Subject to Regulatory Processes in Epithelial–mesenchymal Transitions During Metastases: an Investigation of Human Cancers Transplanted into Severe Combined Immunodeficient Mice , 1998, The Histochemical Journal.
[15] Gregor Mikuz,et al. Ep-CAM overexpression in breast cancer as a predictor of survival , 2000, The Lancet.
[16] T. Hirano,et al. Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. , 1996, British Journal of Cancer.
[17] B. Wollenberg,et al. Tumor necrosis factor α negatively regulates the expression of the carcinoma‐associated antigen epithelial cell adhesion molecule , 2001 .
[18] F. Spyratos,et al. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. , 1990, Cytometry.
[19] G Kvalheim,et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T. Fehm,et al. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Hermann Brenner,et al. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis , 2002, The Lancet.
[22] S. Litvinov,et al. The biology of the 17–1A antigen (Ep-CAM) , 1999, Journal of Molecular Medicine.
[23] E. D. de Vries,et al. Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes , 2003, International journal of cancer.
[24] V. Diehl,et al. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Braun,et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] S. Braun,et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] A. Rahmy,et al. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. , 2002, Journal of clinical pathology.
[28] E. Lane,et al. Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer. , 1996, Human pathology.
[29] T. Reimer,et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] J. Nesland,et al. Immunocytochemical detection of isolated epithelial cells in bone marrow: non‐specific staining and contribution by plasma cells directly reactive to alkaline phosphatase , 1998, The Journal of pathology.
[31] E. Hovig,et al. Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: Gene expression profiles in bone marrow target cells , 2002, International journal of cancer.
[32] T. Dimpfl,et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.
[33] R. Cote,et al. Detection and clinical importance of micrometastatic disease. , 1999, Journal of the National Cancer Institute.
[34] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] H. Bush,et al. Breast Cancer Research , 1978, British Journal of Cancer.
[36] J. Thiery,et al. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule‐positive cells in bone marrow from patients with breast carcinoma , 2004, Cancer.
[37] M. Speicher,et al. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. , 2000, Cancer research.
[38] H Stein,et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[39] J. Packeisen,et al. Detection of surface antigen 17-1A in breast and colorectal cancer. , 1999, Hybridoma.
[40] R. Holle,et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[41] S. Braun,et al. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[42] G Kvalheim,et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. , 1999, Cytotherapy.
[43] J R Siewert,et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. , 2002, Cytometry.
[44] D. Wallwiener,et al. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] Anne Vincent-Salomon,et al. Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients , 2004, Clinical Cancer Research.
[46] Y. Miyoshi,et al. Prognostic Significance of Occult Bone Marrow Micrometastases of Breast Cancer Detected by Quantitative Polymerase Chain Reaction for Cytokeratin 19 mRNA , 2000, Japanese journal of cancer research : Gann.
[47] H. A. Bakker,et al. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule , 1994, The Journal of cell biology.